These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7394067)

  • 21. Developmental abnormalities of terminal deoxynucleotidyl transferase positive bone marrow cells and thymocytes in New Zealand mice: effects of prostaglandin E1.
    Whittum J; Goldschneider I; Greiner D; Zurier R
    J Immunol; 1985 Jul; 135(1):272-80. PubMed ID: 3873491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of captopril on murine systemic lupus erythematosus disease.
    Herlitz H; Svalander C; Tarkowski A; Westberg G
    J Hypertens Suppl; 1988 Dec; 6(4):S684-6. PubMed ID: 2853767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of prostaglandin E by peritoneal macrophages from NZB/W mice.
    Dore-Duffy P; Guha A; Rothman BL; Zurier RB
    Life Sci; 1988; 42(26):2669-76. PubMed ID: 3386406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
    Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
    Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin as an effective antirejection therapy in rat renal allograft recipients.
    Strom TB; Carpenter CB
    Transplantation; 1983 Apr; 35(4):279-81. PubMed ID: 6340282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic studies on the skin lupus band test in New Zealand mice.
    Furukawa F; Maruyama N; Yoshida H; Hamashima Y; Hirose S; Shirai T
    Clin Exp Immunol; 1985 Jan; 59(1):146-52. PubMed ID: 3871675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandins. Their potential in clinical medicine.
    Zurier RB
    Postgrad Med; 1980 Sep; 68(3):70-81. PubMed ID: 7433293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.
    Wang Y; Hu Q; Madri JA; Rollins SA; Chodera A; Matis LA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8563-8. PubMed ID: 8710910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice.
    Mathian A; Weinberg A; Gallegos M; Banchereau J; Koutouzov S
    J Immunol; 2005 Mar; 174(5):2499-506. PubMed ID: 15728455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mononuclear phagocyte system dysfunction in murine SLE: abnormal clearance kinetics precede clinical disease.
    Meryhew NL; Shaver C; Messner RP; Runquist OA
    J Lab Clin Med; 1991 Mar; 117(3):181-93. PubMed ID: 2002275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathology of lupus-like nephritis in Dnase1-deficient mice in comparison to NZB/W F1 mice.
    Jacob M; Napirei M; Ricken A; Dixkens C; Mannherz HG
    Lupus; 2002; 11(8):514-27. PubMed ID: 12220106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunopharmacological actions of lumin (II): Effect of lumin administration in NZB X NZW (B/W) F1 mice].
    Sasaki Y; Nagai N; Okimura T
    Nihon Yakurigaku Zasshi; 1987 Jan; 89(1):9-13. PubMed ID: 2952570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of short-term treatment with the prostaglandin E1 (PGE1) analog misoprostol on inflammatory mediator production in murine lupus nephritis.
    Fan PY; Ruiz P; Pisetsky DS; Spurney RF
    Clin Immunol Immunopathol; 1995 May; 75(2):125-30. PubMed ID: 7704969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prominent renal expression of a murine leukemia retrovirus in experimental systemic lupus erythematosus.
    Alexander JJ; Saxena AK; Bao L; Jacob A; Haas M; Quigg RJ
    J Am Soc Nephrol; 2002 Dec; 13(12):2869-77. PubMed ID: 12444205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of PGE1 in murine models of SLE: changes in circulating immune complexes.
    Winkelstein A; Kelley VE
    Clin Immunol Immunopathol; 1981 Aug; 20(2):188-92. PubMed ID: 7261479
    [No Abstract]   [Full Text] [Related]  

  • 36. Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE).
    Suwannaroj S; Lagoo A; Keisler D; McMurray RW
    Lupus; 2001; 10(4):258-65. PubMed ID: 11341102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The SOD1 transgene expressed in erythroid cells alleviates fatal phenotype in congenic NZB/NZW-F1 mice.
    Otsuki N; Konno T; Kurahashi T; Suzuki S; Lee J; Okada F; Iuchi Y; Homma T; Fujii J
    Free Radic Res; 2016 Jul; 50(7):793-800. PubMed ID: 27080108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation.
    Jacob CO; Hwang F; Lewis GD; Stall AM
    Cytokine; 1991 Nov; 3(6):551-61. PubMed ID: 1686413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of prostaglandin E1 analogue pessaries in patients having first trimester induced abortions.
    Nakano R; Hata H; Sasaki K; Yamoto M
    Br J Obstet Gynaecol; 1980 Apr; 87(4):287-91. PubMed ID: 7426498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone.
    Macanovic M; Sinicropi D; Shak S; Baughman S; Thiru S; Lachmann PJ
    Clin Exp Immunol; 1996 Nov; 106(2):243-52. PubMed ID: 8918569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.